id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-D-0759-0017,FDA,FDA-2017-D-0759,"Drug Products, Including Biological Products, that Contain Nanomaterials Guidance for Industry",Other,Guidance,2022-04-22T04:00:00Z,2022,4,2022-04-22T04:00:00Z,,2024-11-07T00:37:13Z,,1,0,090000648502de08
FDA-2017-D-0759-0016,FDA,FDA-2017-D-0759,"Drug Products, Including Biological
Products, That Contain Nanomaterials;
Guidance for Industry; Availability",Notice,Notice of Availability,2022-04-22T04:00:00Z,2022,4,2022-04-22T04:00:00Z,,2022-04-22T14:14:53Z,2022-08572,0,0,090000648502d74f
FDA-2017-D-0759-0001,FDA,FDA-2017-D-0759,"Drug Products, Including Biological Products, That Contain Nanomaterials; Draft Guidance for Industry; Availability",Notice,Notice of Availability,2017-12-18T05:00:00Z,2017,12,2017-12-18T05:00:00Z,2018-03-20T03:59:59Z,2018-03-20T01:02:36Z,2017-27133,0,0,0900006482d2f9b8
FDA-2017-D-0759-0002,FDA,FDA-2017-D-0759,"Drug Products, Including Biological Products, that Contain Nanomaterials
Guidance for Industry",Other,Guidance,2017-12-18T05:00:00Z,2017,12,2017-12-18T05:00:00Z,2018-03-20T03:59:59Z,2024-11-07T01:13:01Z,,1,0,0900006482d3459a